NEW YORK (GenomeWeb News) – The Two Blades Foundation and Monsanto today announced an expansion of their agreement to provide Monsanto additional TAL Code technologies.

Details about the expansion of the companies' original deal, including financial terms, were not disclosed. Diana Horvath, chief operating officer for the foundation, said in an e-mail that further details "aren't available at this time."

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The US Food and Drug Administration has new guidelines that enable some gene and cell therapies to undergo expedited review, according to the New York Times.

Using gene drives to control invasive species might be too risky, an initial advocate of the approach says.

In Science this week: intellectual property experts argue patent battles such as the one over CRISPR are wasteful, and more.

Researchers have grown tumors in 3D cell cultures to better understand cancer, the Economist reports.